Analysts
Scores, price targets and rating changes published by the firms we track. Informational, not advice.
Price target forecast
The average analyst target through the past year, and where analysts see the price a year from now.
Nov 6, 20260 analyst targets · 90 days
- Share price
- $2.19
- Average 1Y price target
- $8.50+288.13%
- Agreement
- Fair
Analysts agreement range is spread 15% to 30% from the average
Share priceAverage analyst target (90-day window), shaded 10th–90th percentile12-month range from the lowest to the highest current target, dashed to the average
Rating scores
Each factor is scored 1 (weak) to 5 (strong).
- Overall2
- DCF1
- Return on equity1
- Return on assets1
- Debt / equity4
- P/E1
- P/B3
Average price target
Mean of the targets analysts published in each window.
| Window | Targets | Average |
|---|---|---|
| Last month | 0 | — |
| Last quarter | 0 | — |
| Last year | 8 | $10.38 |
| All time | 22 | $6.57 |
Recent rating changes
The latest 40 changes by research firm, newest first.
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 13, 2026 | JP Morgan | maintain | Overweight | Overweight |
| Aug 10, 2026 | Guggenheim | maintain | Buy | Buy |
| May 11, 2026 | HC Wainwright & Co. | maintain | Buy | Buy |
| Mar 23, 2026 | Piper Sandler | maintain | Overweight | Overweight |
| Mar 19, 2026 | Barclays | maintain | Overweight | Overweight |
| Mar 18, 2026 | Jefferies | maintain | Buy | Buy |
| Mar 18, 2026 | Guggenheim | maintain | Buy | Buy |
| Mar 17, 2026 | Wedbush | maintain | Outperform | Outperform |
| Mar 16, 2026 | JP Morgan | upgrade | Neutral | Overweight |
| Mar 16, 2026 | HC Wainwright & Co. | maintain | Buy | Buy |
| Mar 9, 2026 | Guggenheim | maintain | Buy | Buy |
| Feb 4, 2026 | Cantor Fitzgerald | maintain | Overweight | Overweight |
| Feb 4, 2026 | Barclays | maintain | Overweight | Overweight |
| Jan 20, 2026 | Piper Sandler | maintain | Overweight | Overweight |
| Jan 20, 2026 | Barclays | maintain | Overweight | Overweight |
| Nov 11, 2025 | HC Wainwright & Co. | maintain | Buy | Buy |
| Oct 21, 2025 | Barclays | maintain | Overweight | Overweight |
| May 20, 2025 | HC Wainwright & Co. | maintain | Buy | Buy |
| May 15, 2025 | Piper Sandler | maintain | Overweight | Overweight |
| May 15, 2025 | HC Wainwright & Co. | upgrade | Neutral | Buy |
| Apr 14, 2025 | Piper Sandler | maintain | Overweight | Overweight |
| Mar 7, 2025 | HC Wainwright & Co. | maintain | Neutral | Neutral |
| Jan 7, 2025 | HC Wainwright & Co. | maintain | Neutral | Neutral |
| May 28, 2024 | Piper Sandler | upgrade | Neutral | Overweight |
| May 9, 2024 | Wedbush | upgrade | Neutral | Outperform |
| May 9, 2024 | BMO Capital | maintain | Market Perform | Market Perform |
| May 6, 2024 | Jefferies | upgrade | Hold | Buy |
| May 1, 2024 | BMO Capital | maintain | Market Perform | Market Perform |
| Apr 22, 2024 | JP Morgan | upgrade | Underweight | Neutral |
| Mar 12, 2024 | Wedbush | maintain | Neutral | Neutral |
| Mar 12, 2024 | BMO Capital | maintain | Market Perform | Market Perform |
| Nov 9, 2023 | Wedbush | maintain | Neutral | Neutral |
| Nov 8, 2023 | Wedbush | upgrade | Neutral | Outperform |
| Aug 9, 2023 | BMO Capital | maintain | Market Perform | Market Perform |
| Mar 28, 2023 | Mizuho | maintain | Neutral | Neutral |
| Jan 6, 2023 | BMO Capital | maintain | Market Perform | Market Perform |
| Nov 14, 2022 | BMO Capital | downgrade | Outperform | Market Perform |
| Nov 10, 2022 | JP Morgan | downgrade | Overweight | Underweight |
| Jul 11, 2022 | HC Wainwright & Co. | downgrade | Buy | Neutral |
| Jul 11, 2022 | Cowen & Co. | downgrade | Outperform | Market Perform |